Skanditeks subsidiary CMA Microdialysis AB Announces FDA Clearance.

CMA Microdialysis AB announces that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market the ISCUS, a portable Microdialysis Analyzer. Skanditek holds 78 percent of it´s subsidiary CMA Microdialysis. As to the rest, we refer to enclosed press release from CMA Microdialysis AB. Stockholm, May 8, 2006 SKANDITEK INDUSTRIFÖRVALTNING AB (publ) For further information, contact: Patrik Tigerschiöld, President, phone +46 8 614 00 20, mobile +46 70 777 71 90, e-mail patrik.tigerschiold@skanditek.se Philip Siberg, President,CMA Microdialysis mobile +46 70 790 67 43, e-mail philip.siberg@smicrodialysis.se Skanditek is an industrial holding company owning stock in Swedish companies. The business concept is to be an active and long-term stockholder and to further the portfolio companies’ development by providing industrial and financial competence at board and management level. The portfolio comprises 11 companies within technology, biotechnology and services. The major holdings are in Bure Equity (10%), MYDATA automation (96%), PartnerTech (37%), Powerwave (2%) and Vitrolife (28%). Skanditek is listed on the Stockholm Exchange’s O-list.